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Biomimetic, biofunctionalised polymer implants to promote in situ repair of 
traumatic and early osteoarthritic cartilage defects 
 
Introduction: We are developing a biomimetic, implantable medical device which is 
bio-functionalised in a similar conformational and biochemical context to articular 
cartilage, to promote stem cell homing and retention in the implant and subsequent 
chondrogenesis and de novo cartilage formation. The aim of this study was to 
assess the efficacy of this technology on the regeneration of articular cartilage in 
vitro and in vivo.  
Methods: Poly-L-lactic acid (PLLA) random-fibre scaffolds were electrospun and the 
surface charge was altered by plasma polymerisation using allylamine. The surface-
modified scaffolds were treated with heparin and pmol amounts of chondrogenic and 
stem-cell homing factors. The biofunctionalised scaffold was assessed in vitro for its 
ability to support long-term cell viability and chondrogenesis by bone-marrow MSCs 
and primary chondrocytes in the absence of other added growth factors or serum. 
Cell viability was assessed with PrestoBlue® and extracellular matrix (ECM) 
formation determined by measuring glycosaminoglycan content.  The 
biofunctionalised scaffolds were assessed for in vivo activity by implantation into 
surgically-created 6mm chondral lesions in the medial condyles of sheep, with 
microfracture immediately before implantation. At 4 and 16 weeks, the treated joints 
were retrieved and cartilage regeneration assessed macroscopically and 
histologically. 
Results: In vitro, IXQFWLRQDOLVDWLRQRIWKH3//$VFDIIROGZLWKDFRPELQDWLRQRI7*)ȕ
and CXCL12 promoted MSC attachment and ingress throughout the implant, and 
chondrogenic differentiation. Viability of the cells within the construct was maintained 
in the absence of added chondrogenic factors or serum for at least 5-6 weeks. The 
MSCs underwent chondrogenesis and produced significantly more ECM (P0.05) 
than non-functionalised or partially functionalised scaffolds.  The scaffolds also 
promoted chondrocyte attachment, long-term cell viability and ECM formation under 
the same experimental conditions. 
In vivo, LPSODQWDWLRQRI7*)ȕDQG&;&/IXQFWLRQDlised implants showed 
biological efficacy with regeneration of neocartilage with hyaline features 
(determined histologically) occurring at 4 weeks with the bio-functionalised implants 
but the empty defects or control non-functionalised implants. 
Conclusions:  Bio-functionalisation of PLLA scaffolds with pmol quantities of 7*)ȕ
and CXCL12 promoted MSC migration and retention in the scaffolds and 
chondrogenesis with neocartilage tissue regeneration in vitro and in vivo. 
 
